TNFRSF6B and neoplasm: Wu et al reported that DcR3 was not detected in tumor‐free patients but was identified in 98.8% (82 of 83) of patients with malignant cancers,46 indicating that elevated expression levels of DcR3 are significantly correlated with tumorigenesis and tumor progression.